Evofem Biosciences, Inc.

EVFM · OTC · SIC 2834: Pharmaceutical Preparations
329
SEC Filings

Business Summary

Evofem Biosciences, Inc. is a San Diego-based commercial-stage biopharmaceutical company focused on women's sexual and reproductive health. Its primary product, PHEXX (lactic acid, citric acid and potassium bitartrate vaginal gel), is the first FDA-approved non-hormonal prescription contraceptive vaginal gel, launched in September 2020. The company also commercializes SOLOSEC (secnidazole 2g oral granules), a single-dose oral antimicrobial for bacterial vaginosis and trichomoniasis, acquired in July 2024 and relaunched in November 2024.

Next Earnings

Q2 FY2026 — expected 2026-08-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionEVFMdiscussed_in_filing Cybersecurity
topic_mentionEVFMdiscussed_in_filing Trusted Computing
topic_mentionEVFMdiscussed_in_filing Blockchain & Crypto
topic_mentionEVFMdiscussed_in_filing Regulation
topic_mentionEVFMdiscussed_in_filing Automotive
topic_mentionEVFMdiscussed_in_filing Healthcare & Bio
topic_mentionEVFMdiscussed_in_filing Cybersecurity
topic_mentionEVFMdiscussed_in_filing Trusted Computing
topic_mentionEVFMdiscussed_in_filing Blockchain & Crypto
topic_mentionEVFMdiscussed_in_filing Regulation
topic_mentionEVFMdiscussed_in_filing Automotive
topic_mentionEVFMdiscussed_in_filing Healthcare & Bio
topic_mentionEVFMdiscussed_in_filing Cybersecurity
topic_mentionEVFMdiscussed_in_filing Trusted Computing
topic_mentionEVFMdiscussed_in_filing Blockchain & Crypto
topic_mentionEVFMdiscussed_in_filing Regulation
topic_mentionEVFMdiscussed_in_filing Automotive
topic_mentionEVFMdiscussed_in_filing Healthcare & Bio
topic_mentionEVFMdiscussed_in_filing Cybersecurity
topic_mentionEVFMdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-112025-12-310001493152-26-009686EDGAR131K words
2025-03-242024-12-310001641172-25-000188EDGAR
2024-03-272023-12-310001493152-24-011404EDGAR
2023-04-272022-12-310001618835-23-000023EDGAR
2022-03-102021-12-310001618835-22-000057EDGAR
2021-03-042020-12-310001618835-21-000040EDGAR
2020-03-122019-12-310001618835-20-000047EDGAR
2019-03-012018-12-310001618835-19-000031EDGAR
2018-02-262017-12-310001564590-18-003259EDGAR
2017-03-232016-12-310001564590-17-005093EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001493152-25-022275EDGAR44K words
2025-08-142025-06-300001641172-25-023741EDGAR
2025-05-152025-03-310001641172-25-010529EDGAR
2024-11-142024-09-300001493152-24-046060EDGAR
2024-08-142024-06-300001493152-24-031846EDGAR
2024-05-152024-03-310001493152-24-019428EDGAR
2023-11-142023-09-300001493152-23-040764EDGAR
2023-08-142023-06-300001493152-23-028671EDGAR
2023-06-162023-03-310001493152-23-021701EDGAR
2023-01-062022-09-300001618835-23-000001EDGAR
2022-08-122022-06-300001618835-22-000166EDGAR
2022-05-102022-03-310001618835-22-000110EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001493152-26-011613EDGAR1K words
2026-03-110001493152-26-009689EDGAR
2026-01-120001493152-26-001886EDGAR
2025-11-260001493152-25-025172EDGAR
2025-11-130001493152-25-022318EDGAR
2025-10-200001493152-25-018687EDGAR
2025-10-170001493152-25-018454EDGAR
2025-08-260001641172-25-025530EDGAR
2025-08-140001641172-25-023740EDGAR
2025-07-020001641172-25-017563EDGAR

329 total filings indexed. 297 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

women's-sexual-and-reproductive-health prescription-contraception antimicrobial-treatment-for-vaginal-infections middle-east-and-north-africa-(mena)-pharmaceutical-markets

Company Identity

CIK0001618835
TickerEVFM
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersSan Diego, California

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0aba834e3bfae8ae57b18283627c1022ee40d54180410945f9dd23c4dd0baaec
parent: 2ca0bcaeb125663b0210f84ae030e503acd77df6c8ee732dfca6d522fbf62352
content hash: 5f09506bf45cd246082a48d5407a6b0b76ecb90841d3f25576b796c8eb99c3c4
signed: 2026-04-13T04:44:56.532Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf